Presentation TCT 2016 Future Therapy for Symptomatic HCM Patients With and Without Dynamic Obstruction Presenter: George S. Hanzel, Antoine Lafont, Michael A. Fifer October 30, 2016
Presentation TCT 2016 Debate: Surgery, Septal Ablation or New Medical Therapy for Obstructive HCM - Septal Ablation Is As Good As Surgery and Less Invasive! Presenter: George S. Hanzel, Antoine Lafont, Carey D. Kimmelstiel October 30, 2016
Presentation TCT 2016 Debate: Surgery, Septal Ablation or New Medical Therapy for Obstructive HCM - Surgery Is Always the First Option! Presenter: George S. Hanzel, Antoine Lafont, Daniel G Swistel October 30, 2016
Presentation TCT 2016 Debate: Surgery, Septal Ablation or Medical Therapy for Obstructive HCM Not so Fast: Try Optimizing Medical Therapy First! Presenter: George S. Hanzel, Antoine Lafont, Michael A. Fifer October 30, 2016
Presentation TCT 2016 Novel Approaches for Septal Ablation: Beyond Alcohol Presenter: Srihari S. Naidu, Paul Sorajja October 30, 2016
Presentation TCT 2016 Alcohol Septal Ablation of Ventricular Tachycardia Presenter: Srihari S. Naidu, Paul Sorajja, George D. Dangas October 30, 2016
Presentation TCT 2016 An Alcohol Septal Ablation Case I Regret Presenter: Srihari S. Naidu, Paul Sorajja October 30, 2016
Presentation TCT 2016 My Best Alcohol Septal Ablation Case Presenter: Srihari S. Naidu, Paul Sorajja, George S. Hanzel October 30, 2016
Presentation TCT 2016 Good and Not So Good Cases to Consider for Alcohol Septal Ablation Presenter: Srihari S. Naidu, Paul Sorajja, John S. Douglas Jr October 30, 2016
Presentation TCT 2016 Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro Pacing Presenter: Bernard J. Gersh, Harry Rakowski, Michael A. Fifer October 30, 2016
Presentation TCT 2016 Debate: ICD or Pacemaker for High Grade AV Block After Alcohol Septal Ablation: Pro ICD! Presenter: Bernard J. Gersh, Harry Rakowski, George S. Hanzel October 30, 2016
Presentation TCT 2016 When Is Pacing Needed in HCM Outside Invasive Management Settings Presenter: Bernard J. Gersh, Harry Rakowski October 30, 2016
Presentation TCT 2016 Medical Management of Non-Obstructive HCM: When and Which Medications? Presenter: Bernard J. Gersh, Harry Rakowski, John S. Douglas Jr October 30, 2016
Presentation TCT 2016 Genetic Testing in Hypertrophic Cardiomyopathy: Role in Prognostication and Screening Presenter: Howard C. Herrmann, Sherif F. Nagueh, Robert Roberts October 30, 2016
Presentation TCT 2016 Cardiac Catheterization Is Essential for Hemodynamic Assessment Presenter: Howard C. Herrmann, Sherif F. Nagueh October 30, 2016
Presentation TCT 2016 Cardiac MR for Diagnosis and Guiding Management of HCM Presenter: Howard C. Herrmann, Sherif F. Nagueh, Andrew E. Arai October 30, 2016
Presentation TCT 2016 Echocardiography Essentials for Comprehensive Evaluation of HCM Presenter: Howard C. Herrmann, Sherif F. Nagueh October 30, 2016
News Industry News Heart Metabolics Announces Initiation Of Phase 2b Study Of Perhexiline For Hypertrophic Cardiomyopathy August 31, 2016
News Daily News Las Pruebas Genéticas No son Necesariamente la Prueba Concluyente en el Diagnóstico de la CMH Yael L. Maxwell August 23, 2016